Beta-lactam/beta-lactamase inhibitor combinations in empiric management of pediatric infections

Journal of International Medical Research

Volumn 30, Issue SUPPL. 1, 2002, Pages

  Adam, D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ampicillin sulbactam; Beta lactam resistance; Beta lactamase inhibitor; Combination therapy; Sultamicillin

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOPERAZONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; CLOXACILLIN; COTRIMOXAZOLE; LIDOCAINE; METICILLIN; NAFCILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; SULBACTAM; SULTAMICILLIN; TAZOBACTAM; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG RESPONSE; DRUG TISSUE LEVEL; DRUG TOLERABILITY; ENZYME SYNTHESIS; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; KLEBSIELLA; LOWER RESPIRATORY TRACT INFECTION; MENINGITIS; MORAXELLA CATARRHALIS; NEWBORN; OSTEOMYELITIS; PSEUDOMONAS AERUGINOSA; RASH; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

EID: 0036185106     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/14732300020300s103     Document Type: Article

References (42)

1. In vitro efficacy of β-lactam/β-lactamase inhibitor combinations against bacteria involved in mixed infections
2. Beta-lactam antibiotics: Their role in the management of infections in children
3. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - Findings of the Alexander Project 1992-1996
4. An enzyme from bacteria able to destroy penicillin
5. Quantitative action of penicillin inhibitor from penicillin resistant strains of staphylococci
6. Properties of penicillin inactivator extracted from penicillin-resistant staphylococci
7. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae
8. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin
9. Long-term trends in susceptibility of Moraxella catarrhalis: A population analysis
10. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens 1992-1993: The Alexander Project
11. Survey of the prevalence of β-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital
12. Antimicrobial resistance in Bacteroides
13. Impact of β-lactamases on the clinical use of β-lactam antibiotics
14. The evolution of resistance to cephalosporins
15. Bacterial resistance to carbapenems
16. Clavulanic acid: A beta-lactamase inhibiting beta-lactam from Streptomyces clavuligerus
17. Inhibition of the β-lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins
18. Sultamicillin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
19. In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections
20. Worldwide clinical experience with sultamicillin
21. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae
22. Induction/inhibition of chromosomal β-lactamases by β-lactamase inhibitors
23. CP-45, 899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae and Bacteroides
24. Sulbactam/ampicillin: In vitro spectrum, potency, and activity in models of acute infection
25. Pharmacokinetics of sulbactam/ampicillin in humans: A review
26. Sulbactam/ampicillin: A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use
27. The pharmacokinetics of sultamicillin
28. An open comparative study of the efficacy and safety of sultamicillin versus cefaclor in the treatment of acute otitis media in children
29. Low-dose sultamicillin oral suspension in the treatment of mild to moderate paediatric infections in Turkey
30. Observations on oral sultamicillin/Unasyn CP-45 899 therapy of neonatal infections
31. Treatment of bacterial infections in children with sultamicillin
32. Worldwide pediatric experience with low-dose sultamicillin oral suspension
33. Clinical use of sultamicillin (ampicillin/sulbactam) in children
34. Efficacy and safety of sultamicillin (750 mg bid) compared with amoxycillin/clavulanate (625 mg tid) in patients with uncomplicated urinary tract infections
35. Sulbactam plus ampicillin: Interim review of efficacy and safety for therapeutic and prophylactic use
36. Clinical experience with sulbactam/ampicillin (Unasyn)
37. Improving compliance with antibiotic regimens for otitis media. Randomized clinical trial in a pediatric clinic
38. Antibiotic prescribing practices and patient compliance in the community
39. Patient compliance in therapeutic practice
40. Patient compliance with antibiotic regimens
41. Overview of patient compliance with medication dosing: A literature review